Current | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

Celera Corporation First Quarter Fiscal 2009 Results and Conference Call Scheduled for May 6, 2009

ALAMEDA, CA - April 23, 2009

Celera Corporation (NASDAQ:CRA) announced today that it will issue first quarter fiscal 2009 financial results on Wednesday, May 6, 2009. Results are scheduled for release after the close of trading on the NASDAQ stock market. Kathy Ordoñez, Chief Executive Officer, and Ugo DeBlasi, Chief Financial Officer, will lead a conference call the same day at 4:30 p.m. (ET) to discuss these results and other matters related to the business.

The management team will make prepared remarks and answer questions from securities analysts and investment professionals. Investors, securities analysts, representatives of the media and other interested parties who would like to participate should dial ( 866) 510-0676 , or (617) 597-5361 for international callers, and enter passcode 62798924 at any time from 4:15 p.m. (ET) until the end of the call. This conference call will also be webcast. Interested parties who wish to listen to the webcast should visit the “Media and Investors” section on . A digital recording will be available approximately two hours after the completion of the conference call on May 6 until May 20, 2009. Interested parties should call ( 888) 286-8010, or (617) 801-6888 for international callers, and enter passcode 15169117.

About Celera
Celera is a healthcare business delivering personalized disease management through a combination of products and services incorporating proprietary discoveries. Berkeley HeartLab, a subsidiary of Celera, offers services to predict cardiovascular disease risk and improve patient management. Celera also commercializes a wide range of molecular diagnostic products through Abbott and has licensed other relevant diagnostic technologies developed to provide personalized disease management in cancer and liver diseases. Information about Celera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at .

Copyright© 2009. Celera Corporation. All Rights Reserved. Celera is a registered trademark of Celera Corporation or its subsidiaries in the U. S. and/or certain other countries.

David Speechly, Ph.D.
+1 (510) 749-1853

Notice To Readers: Celera's press releases, presentations and printed remarks are included on this website for historical purposes only. The information contained in these documents should be considered accurate only as of the date of the relevant document. This information may change over time, and therefore visitors to this website should not assume that the information contained in these documents remains accurate at a later time. We do not have any current intention to update any of the information in these documents.